Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

NeuroOne Medical Technologies Corporation Common Stock (NMTC)

Surgical & Medical Instruments & Apparatus

https://www.n1mtc.com

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

7599 ANAGRAM DR
EDEN PRAIRIE, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/09/2012

Market Cap

19,879,259

Shares Outstanding

25,310,000

Weighted SO

25,311,404

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BSGM --.--%

NMRD --.--%

BMRA --.--%

XAIR --.--%

MOVE --.--%

SNWV --.--%

DYNT --.--%

LNSR --.--%

NPCE --.--%

Beta

0.9520

Last Div

0.0000

Range

0.602-2.0

Chg

-0.0160

Avg Vol

110553

Mkt Cap

19879259

Exch

NASDAQ

Country

US

Phone

952 426 1383

DCF Diff

2.0987

DCF

-1.0387

Div Yield

0.0000

P/S

5.0680

EV Multiple

-1.5323

P/FV

6.4846

Div Yield %

0.0000

P/E

-1.6137

PEG

-1.2109

Payout

0.0000

Current Ratio

2.4160

Quick Ratio

1.3554

Cash Ratio

0.9580

DSO

38.2030

DIO

234.6045

Op Cycle

272.8075

DPO

99.3212

CCC

173.4863

Gross Margin

0.2887

Op Margin

-3.1192

Pretax Margin

-3.0854

Net Margin

-3.0854

Eff Tax Rate

-0.0015

ROA

-2.4636

ROE

-2.7610

ROCE

-3.7978

NI/EBT

1.0000

EBT/EBIT

0.9892

EBIT/Rev

-3.1192

Debt Ratio

0.0427

D/E

0.0697

LT Debt/Cap

0.0652

Total Debt/Cap

0.0652

Int Coverage

0.0000

CF/Debt

-42.3390

Equity Multi

1.6312

Rec Turnover

9.5542

Pay Turnover

3.6749

Inv Turnover

1.5558

FA Turnover

5.2001

Asset Turnover

0.7985

OCF/Share

-0.3249

FCF/Share

-0.3295

Cash/Share

0.0592

OCF/Sales

-2.2657

FCF/OCF

1.0142

CF Coverage

-42.3390

ST Coverage

0.0000

CapEx Coverage

-70.4727

Div&CapEx Cov

-70.4727

P/BV

6.4846

P/B

6.4846

P/S

5.0680

P/E

-1.6137

P/FCF

-2.2055

P/OCF

-2.1975

P/CF

-2.1975

PEG

-1.2109

P/S

5.0680

EV Multiple

-1.5323

P/FV

6.4846

DPS

0.0000

Latest Headlines (EST)

Investing.com Jul 13, 04:03 NeuroOne faces Nasdaq delisting over share price woe - Investing.com GlobeNewswire Inc. Dec 07, 16:30 NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14 GlobeNewswire Inc. Nov 14, 17:15 NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation